Pfizer BioNtech vaccine
A decision is expected next month by European Health Regulators on the use of the Pfizer BioNtech Covid-19 vaccine on children under 12.
The EMA is examining an application to authorise its use on children, aged 5 to 11.
Marco Cavaleri of the EMA, says a decision should be made in December unless additional data is needed:
#Comirnaty for children aged 5 to 11: conclusion expected in December. This is a shortened timetable compared to similar reviews. We will also consider further data collected and submitted by BioNTech/Pfizer from an ongoing paediatric trial. #EMAPresser
— EU Medicines Agency (@EMA_News) November 4, 2021
Yesterday it was announced children as young as 5 will be offered Covid-19 vaccinations in the United States.
The Centres for Disease Control and Prevention recommended the rollout of the Pfizer-BioNtech vaccine, to children aged 5 - 11.
The recommendation will now expand vaccine access to approximately 28 million children in the US.
Vaccinations can begin immediately.
Children under 12 will receive a paediatric dose, which is one third the dosage of an adult vaccine.
Eurovision Song Contest Begins Tonight As Ireland And Other Countries Boycott
WHO Expects More Hantavirus Cases Among The Cruise Ship Passengers
Two Irish Passengers On Virus-Stricken Cruise Ship Now In Care Of HSE
Musical Stars Announced for 2026 World Cup Opening
Irish Citizens On Virus-Stricken Ship "Safe And Well", As Protests Break Out In Tenerife
WHO Confirms Five Cases Of Hantavirus
Human-To-Human Transmission Suspected To Be Cause Of Hantavirus Outbreak On Cruise Ship
Fresh Doubts Over Ceasefire Between US And Iran Following Reported Strikes In UAE
